Log In

Forgot Password?


Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

2022 Annual Meeting | C125 - Neuropsychiatric Considerations in Epilepsy

Wednesday 04/06/22
07:00 AM - 09:00 AM PDT Add To Calendar
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
David L. Perez, MD, FAAN
Epilepsy/Clinical Neurophysiology (EEG)
Neuropsychiatric considerations occur frequently and in a multitude of ways in patients with seizures. Patients with epilepsy have higher rates of neuropsychiatric symptoms than the general population, including anxiety, depression, and cognitive symptoms; psychosocial difficulties are also important considerations in this population. Managing anti-seizure medications while taking into account mental health co-morbidities and psychopharmacology provide additional layers of complexity. Finally, one in five patients with functional seizures also has co-morbid epileptic seizures, creating both diagnostic and therapeutic challenges. This course is designed to help attendees bridge the Neurology-Psychiatry gap in assessing and managing patients with seizures by providing attendees with an integrative neuropsychiatric perspective that can be leveraged to guide longitudinal care. The course is structured in a case-based format to ensure that the educational information provided is readily translatable to clinical encounters. Upon completion participants will have learned: an overview of the components of the neuropsychiatric perspective that can be leveraged to provide patient-centered care to patients with seizures; how to use the biopsychosocial framework to guide treatment planning for patients with seizures; a practical approach to pharmacotherapy, including anti-seizure medications, and psychotherapy recommendations in patients with epilepsy experiencing co-morbid psychiatric symptoms; and evidence-based approach to differentiating epileptic vs. functional seizures, and available management strategies for functional seizures.
2.00 CME credits
Patient Care & Procedural Skills, Interpersonal and Communication Skills, Medical Knowledge, Practice-based Learning and Improvement
Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student
Case-based, Didactic, Audience Participation

Program Materials Program Evaluations

Event Timeline
07:00 AM - 07:05 AM PDT Introduction Introduction – Outline of Content & Speakers
David L. Perez, MD, FAAN
07:00 AM - 07:00 AM PDT Speaker Walk-in Slides
David L. Perez, MD, FAAN
07:05 AM - 07:35 AM PDT Speaker Neuropsychiatry: Bridging Brain, Mind and Body
David L. Perez, MD, FAAN
07:35 AM - 08:05 AM PDT Speaker Epilepsy and Major Psychiatric Comorbidities: A Patient-centered Approach
Aneeta Saxena, MD
08:05 AM - 08:35 AM PDT Speaker Comorbid Functional and Epileptic Seizures: Dual Diagnosis Challenges
Sara A. Finkelstein, MD
08:35 AM - 09:00 AM PDT Q&A Questions & Answers
David L. Perez, MD, FAAN, Sara A. Finkelstein, MD, Aneeta Saxena, MD
Faculty Disclosures
David L. Perez, MD, FAAN Dr. Perez has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley: Brain and Behavior. The institution of Dr. Perez has received research support from NIH. The institution of Dr. Perez has received research support from Sidney R. Baer Jr. Foundation. Dr. Perez has received publishing royalties from a publication relating to health care.
Sara A. Finkelstein, MD Dr. Finkelstein has received personal compensation in the range of $500-$4,999 for serving as a Speaker at Annual Fall Meeting with Massachusetts Neurologic Association.
Aneeta Saxena, MD An immediate family member of Dr. Saxena has received personal compensation for serving as an employee of BIogen.